BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28588274)

  • 1. Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study.
    Weberpals J; Jansen L; Haefeli WE; Hoffmeister M; Wolkewitz M; Herk-Sukel MPPV; Vissers PAJ; Brenner H
    Sci Rep; 2017 Jun; 7(1):2911. PubMed ID: 28588274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
    Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
    Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.
    Jansen L; Weberpals J; Kuiper JG; Vissers PAJ; Wolkewitz M; Hoffmeister M; Brenner H
    Int J Cancer; 2017 Jul; 141(1):62-71. PubMed ID: 28370155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.
    Livingstone E; Hollestein LM; van Herk-Sukel MP; van de Poll-Franse L; Nijsten T; Schadendorf D; de Vries E
    Eur J Cancer; 2013 Dec; 49(18):3863-71. PubMed ID: 23942335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer.
    Assayag J; Pollak MN; Azoulay L
    Eur J Cancer; 2014 Nov; 50(16):2838-45. PubMed ID: 25204805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between perioperative beta blocker use and cancer survival following surgical resection.
    Musselman RP; Bennett S; Li W; Mamdani M; Gomes T; van Walraven C; Boushey R; Al-Obeed O; Al-Omran M; Auer RC
    Eur J Surg Oncol; 2018 Aug; 44(8):1164-1169. PubMed ID: 29858097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries.
    Seigneurin A; Delafosse P; Trétarre B; Woronoff AS; Velten M; Grosclaude P; Guizard AV; Lapôtre-Ledoux B; Bara S; Molinié F; Colonna M
    BMC Cancer; 2018 Nov; 18(1):1091. PubMed ID: 30419850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-Blocker Use and Lung Cancer Mortality in a Nationwide Cohort Study of Patients with Primary Non-Small Cell Lung Cancer.
    Udumyan R; Montgomery S; Fang F; Valdimarsdottir U; Hardardottir H; Ekbom A; Smedby KE; Fall K
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):119-126. PubMed ID: 31641010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.
    Couttenier A; Lacroix O; Silversmit G; Vaes E; De Schutter H; Robert A
    Cancer Epidemiol; 2019 Oct; 62():101579. PubMed ID: 31450179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy.
    Grytli HH; Fagerland MW; Fosså SD; Taskén KA; Håheim LL
    Prostate; 2013 Feb; 73(3):250-60. PubMed ID: 22821802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma.
    Udumyan R; Montgomery S; Fang F; Almroth H; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
    Cancer Res; 2017 Jul; 77(13):3700-3707. PubMed ID: 28473530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of ß-blocker use in patients with stable coronary artery disease.
    Bauters C; Lemesle G; Meurice T; Tricot O; de Groote P; Lamblin N
    Heart; 2014 Nov; 100(22):1757-61. PubMed ID: 24947319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction.
    Goldberger JJ; Bonow RO; Cuffe M; Liu L; Rosenberg Y; Shah PK; Smith SC; Subačius H;
    J Am Coll Cardiol; 2015 Sep; 66(13):1431-41. PubMed ID: 26403339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
    Grytli HH; Fagerland MW; Fosså SD; Taskén KA
    Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-specific associations between beta blocker use and prognosis after colorectal cancer.
    Jansen L; Hoffmeister M; Arndt V; Chang-Claude J; Brenner H
    Cancer; 2014 Apr; 120(8):1178-86. PubMed ID: 24415516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2008 Jul; 52(3):190-9. PubMed ID: 18617067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pre existing respiratory conditions on survival of lung cancer patients: A nationwide population-based cohort study.
    Hong S; Park EC; Kim TH; Kwon JA; Yoo KB; Han KT; Yoo JW; Kim SJ
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e71-e80. PubMed ID: 28762660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Kim JH; Ahn YK; Jeong MH; Choi DJ; Park JS; Kim YJ; Park HS; Han KR; Rha SW; Gwon HC
    JACC Cardiovasc Interv; 2014 Jun; 7(6):592-601. PubMed ID: 24947717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
    de Vries F; Souverein PC; Cooper C; Leufkens HG; van Staa TP
    Calcif Tissue Int; 2007 Feb; 80(2):69-75. PubMed ID: 17308987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.